Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Hordinsky

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Dermatology|June 13, 2025
Response to Ezzat et al., "Response to Rypka et al., 'A Single Center Retrospective Cohort Study of Hydroxychloroquine-Related Adverse Events in Adults with Lymphocytic Cicatricial Alopecia'"Maria Teachout, Katelyn J Rypka, James T Pathoulas, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2025
INDIVIDUAL ARTICLE: Etiology, Treatment Challenges, and the Role of Scalp and Haircare in Managing DandruffMaria Hordinsky, Anneke Andriessen, Doris Day, et al.
Journal of Drugs in Dermatology : JDD|June 5, 2023
Gender-Affirming Hormone Therapy Among Transgender and Gender Diverse Patients Receiving Laser Hair Removal Prior to Gender-Affirming SurgeryGretchen Bellefeuille, Katherine Plampton, Rumbidzai Ngonyama, et al.
The British Journal of Dermatology|June 2, 2023
Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burdenKristina Gorbatenko-Roth, Sarah Wood, Mattea Johnson, et al.
JAAD Case Reports|May 3, 2024
Use of artificial intelligence to track platelet-rich plasma treatment outcomes in females with nonscarring alopecia: A case seriesOra Raymond, Javed Shaik, Katelyn Rypka, et al.
Journal of the American Academy of Dermatology|August 28, 2002
Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trialJames Leyden, Alan Shalita, Maria Hordinsky, et al.
Dermatology (Basel, Switzerland)|August 10, 2010
Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trialMaria Hordinsky, Alan Fleischer, Jason K Rivers, et al.
Journal of Genetic Counseling|October 13, 2019
Familial implications of autoimmune disease: Recurrence risks of alopecia areata and associated conditions in first-degree relativesKatherine Agre, Patricia McCarthy Veach, Heather Bemmels, et al.
Journal of the American Academy of Dermatology|January 12, 2020
Fibrosing alopecia in a pattern distributionJacob Griggs, Ralph M Trüeb, Maria Fernanda Reis Gavazzoni Dias, et al.
Journal of the American Academy of Dermatology|July 25, 2020
Integrating colocated behavioral health care into a dermatology clinic: A prospective randomized controlled treatment pilot study in patients with alopecia areataKristina Gorbatenko-Roth, James S Hodges, Dayna Lifson, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Dermatology|June 13, 2025
Response to Ezzat et al., "Response to Rypka et al., 'A Single Center Retrospective Cohort Study of Hydroxychloroquine-Related Adverse Events in Adults with Lymphocytic Cicatricial Alopecia'"Maria Teachout, Katelyn J Rypka, James T Pathoulas, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2025
INDIVIDUAL ARTICLE: Etiology, Treatment Challenges, and the Role of Scalp and Haircare in Managing DandruffMaria Hordinsky, Anneke Andriessen, Doris Day, et al.
Journal of Drugs in Dermatology : JDD|June 5, 2023
Gender-Affirming Hormone Therapy Among Transgender and Gender Diverse Patients Receiving Laser Hair Removal Prior to Gender-Affirming SurgeryGretchen Bellefeuille, Katherine Plampton, Rumbidzai Ngonyama, et al.
The British Journal of Dermatology|June 2, 2023
Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burdenKristina Gorbatenko-Roth, Sarah Wood, Mattea Johnson, et al.
JAAD Case Reports|May 3, 2024
Use of artificial intelligence to track platelet-rich plasma treatment outcomes in females with nonscarring alopecia: A case seriesOra Raymond, Javed Shaik, Katelyn Rypka, et al.
Journal of the American Academy of Dermatology|August 28, 2002
Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trialJames Leyden, Alan Shalita, Maria Hordinsky, et al.
Dermatology (Basel, Switzerland)|August 10, 2010
Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trialMaria Hordinsky, Alan Fleischer, Jason K Rivers, et al.
Journal of Genetic Counseling|October 13, 2019
Familial implications of autoimmune disease: Recurrence risks of alopecia areata and associated conditions in first-degree relativesKatherine Agre, Patricia McCarthy Veach, Heather Bemmels, et al.
Journal of the American Academy of Dermatology|January 12, 2020
Fibrosing alopecia in a pattern distributionJacob Griggs, Ralph M Trüeb, Maria Fernanda Reis Gavazzoni Dias, et al.
Journal of the American Academy of Dermatology|July 25, 2020
Integrating colocated behavioral health care into a dermatology clinic: A prospective randomized controlled treatment pilot study in patients with alopecia areataKristina Gorbatenko-Roth, James S Hodges, Dayna Lifson, et al.
Pageof 8